Benefits

NorCOMM provides Canadian biotech clients with convenient, cost-effective access to comprehensive mouse mutagenesis resources and functional genetics preclinical services.

NorCOMM provides an invaluable tool to generate exhaustive panels of novel mouse mutants:

• Enabling rigorous, efficient analysis of targets and pathways; and
• Enhancing capacity to examine potential off-target effects during preclinical screening—improving the design, and therefore the cost, of clinical investigation.